Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
boston top stories
life sciences
national blog main
3
×
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
intercept pharmaceuticals
national
nonalcoholic steatohepatitis
obeticholic acid
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
abbvie
acne
agenus
alirocumab
allergan
amgen
astrazeneca
What
drug
3
×
known
3
×
approved
disease
fatty
liver
nash
new
bio
cholesterol
companies
data
digital
drugs
epidemic
expensive
faces
fda
financial
foe
frenzied
growing
healthcare
hint
horizon
inhibitors
intercept
led
lowering
marketed
medicine
merck
news
nonalcoholic
pcsk
race
remember
roundup
steatohepatitis
strikes
Language
unset
Current search:
known
×
photo
×
" national blog main "
×
drug
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug